NOVADEL PHARMA INC·5

Sep 27, 7:03 PM ET

Abd El-Shafy Mohammed 5

5 · NOVADEL PHARMA INC · Filed Sep 27, 2004

Insider Transaction Report

Form 5
Period: 2004-07-31
Abd El-Shafy Mohammed
VP, Pharmaceutical Development
Transactions
  • Award

    Stock Option (Right to Buy)

    2002-05-21+150,000150,000 total
    Exercise: $3.02Exp: 2010-05-20Common Stock (150,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2004-02-24+50,00050,000 total
    Exercise: $1.65From: 2004-02-24Exp: 2009-02-23Common Stock (50,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2003-03-28+50,00050,000 total
    Exercise: $1.51From: 2003-03-28Exp: 2008-03-27Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]The Options vest in three annual installments: 50,000 options become exercisable on November 15, 2002; 50,000 options become exercisable on May 15, 2003; and 50,000 options become exercisable on May 15, 2004.

Documents

1 file
  • 5
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT